Esophageal Disease and the Role of the Microbiome

David A. Johnson

ISBN 10: 0323950701 / ISBN 13: 9780323950701

Published by Elsevier Science & Technology Nov 2022, 2022

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -Esophageal Diseases and the Role of the Microbiome provides evidence on biomic influence in esophageal diseases. The book builds on the translational information on H pylori for ulcer disease as well as the explosive focus on biomic influence in virtually all areas of esophageal diseases. This important reference will help translational researchers by providing scientific understanding and hypothesis generation that is needed for furthering this field of study. It will also provide clinicians with disease management options for esophageal diseases (for GERD and PPI options/side effects) and present cutting-edge science to promote provider/patient understanding and options. 214 pp. Englisch.

Seller Inventory # 9780323950701

Bibliographic Details

• Title: Esophageal Disease and the Role of the Microbiome
• Publisher: Elsevier Science & Technology Nov 2022
• Publication Date: 2022
• Language: English
• ISBN 10: 0323950701
• ISBN 13: 9780323950701
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 229W x 151H x 16D millimeters 229 millimeters width by 151 millimeters height by 16 millimeters depth
• Weight: 366 grams

About this title

Synopsis

Esophageal Diseases and the Role of the Microbiome provides evidence on biomic influence in esophageal diseases. The book builds on the translational information on H pylori for ulcer disease as well as the explosive focus on biomic influence in virtually all areas of esophageal diseases. This important reference will help translational researchers by providing scientific understanding and hypothesis generation that is needed for furthering this field of study. It will also provide clinicians with disease management options for esophageal diseases (for GERD and PPI options/side effects) and present cutting-edge science to promote provider/patient understanding and options.

• Delivers a translational understanding of new paradigms for esophageal disease
• Explains the effects of microbiome balance in the esophagus
• Suggests potential treatment options of esophageal dysbiosis

About the Author

Dr. Johnson MD, MACG, FASGE, MACP is Professor of Medicine and Chief of Gastroenterology at Eastern VA School of Medicine. He co-founded the National Medicare Carrier Advisory Committee. He served on the GI Multi-Society CRC Screening Task Force and ACG guidelines committee for CRC screening, and co-authored the national guidelines. He served on the American Board of Internal Medicine (Gastroenterology), Board of Examiners (2012-2017), and was reappointed to the Maintenance of Certification ABIM Board 2020-present. He has been honored with the highest award from the American College of Gastroenterology; the Berk/Fise Award for lifetime achievements, as well as the William D Carey ACG Governors award to lifetime contributions to gastroenterology. He is the physician who worked with Virginia State Senator Emily Couric to put through the historic legislation to mandate colon cancer screening with colonoscopy as the preferred standard. This initiative has set the model for other states which have followed with similar legislation.